| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chf Clinical Develop Officer | EVP, Chf Clinical Develop Offc
1 company
Eugene Schneider is EVP, Chf Clinical Develop Officer at IONS. From January 2021 to June 2026, the filings on record show 0 open-market purchases and 14 sales. Eugene Schneider's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $3.2M at current prices.
Historically, Eugene Schneider's trades have earned a middling insider score of 63/100 across 14 rated trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -13.2%.
The IONS filings lean toward selling, a net 131,225 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2024 | IONS Ionis Pharmaceuticals Inc | EVP, Chf Clinical Develop Officer | Sale+OE10b5-1 | 8,000 | $53.50 | $427,999.20 | -17.3% | -20.6% | -37.5% | |
| Dec 26, 2023 | IONS Ionis Pharmaceuticals Inc | EVP, Chf Clinical Develop Officer | Sale+OE10b5-1 | 25,000 | $51.46 | $1,286,575.00 | -40.9% | -14.4% | -29.2% | |
| Feb 6, 2023 | IONS Ionis Pharmaceuticals Inc | EVP, Chf Clinical Develop Officer | Sell | 1,413 | $40.67 | $57,464.17 | -5.4% | -13.1% | +21.3% | |
| Jan 18, 2023 | IONS Ionis Pharmaceuticals Inc | EVP, Chf Clinical Develop Officer | Sale+OE | 4,752 | $39.57 | $188,051.85 | -17.5% | -8.6% | +27.2% |